About us

Our SME is developing and licensing novel more energy-efficient biotreatment technologies for low-grade ores, tailings and different type of waste to meet the goals of Fit for 55! and Green Deal. Our aim is to lower the EU's dependency on critical raw materials (CRMs) from geopolitically unstable countries. Given CRMs are vital for the success of renewable energy growth.

Our R&D company formerly known as BiotaP was created already in July 2007 with main focus at developing environment monitoring tools based on metagenomics. For 10 years our ISO 17025 accredited laboratory performed DNA analysis of microorganisms extracted from environmental and medical samples mainly for scientific institutions home and abroad.

As we fell in love with micro-organisms, we decided to start investigating their world further. In 2010 we began looking for the hungriest little miners among the micro-organisms with the aim to hire them to the workforce in new innovative bioleaching technology for different ores and type of waste. 

First tests run with local Dictyonema Argillite were promising, and the development of 2 step technology comprising both anaerobic and aerobic bioleaching in stirred tanks continued, resulting with the patent application in 2016. With the Green deal Grant from European Innovation Council in 2020 we are equipping our BioMining Centre further and setting up pilot-scale biotreatment unit with 1m3 reactors.

Like greedy barons, we are currently looking for other raw materials suitable for our tiny miners' army. R&D is going on with amending the technology for e-waste, oil shale, red mud and for old lubricating oils.

Preliminary tests show that our different biotreatment approaches are suitable for maximum valorization in an environmentally-safe way of:

- argillite
- WEEE (Waste Electrical & Electronic Equipment; often called as e-waste)

- Bauxite Residue

- black shales & oil shales
- phosphate rocks
- dolomite fine fraction waste
- other metals/organics containing secondary waste and ores.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101010499.